ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Long-Term Deferred Tax (2022 - 2024)

Updated

ProPhase Labs' Long-Term Deferred Tax was $14.58 million in Q3 2024, up 280.4% from $3.83 million a year earlier and up 21.0% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Long-Term Deferred Tax (2022 - 2024) Analysis & Trends

At the end of FY2023, Long-Term Deferred Tax at ProPhase Labs came in at $7.31 million.

  • The Q3 2024 figure marks the highest quarterly Long-Term Deferred Tax in data going back to Q2 2022.
  • Per Business Quant data, PRPH's Long-Term Deferred Tax in the three quarters before Q3 2024 was $12.05 million (Q2 2024), $9.76 million (Q1 2024) and $7.31 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 14.58 Mn
Jun 30, 2024 12.05 Mn
Mar 31, 2024 9.76 Mn
Dec 31, 2023 7.31 Mn
Sep 30, 2023 3.83 Mn
Jun 30, 2023 1.48 Mn
Mar 31, 2023 191,000.00
Sep 30, 2022 1.34 Mn
Jun 30, 2022 594,000.00
API Access

ProPhase Labs Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PRPH&period=max&api_key=YOUR_API_KEY